AstraZeneca Pharma India Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

5.00

5.00

5.00

5.00

5.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

583.69

506.39

451.17

359.44

295.80

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

588.69

511.39

456.17

364.44

300.80

Uses of funds

Fixed assets

Gross block

165.14

158.64

159.78

132.84

119.83

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

96.28

84.15

78.82

61.31

45.00

Net block

68.86

74.49

80.96

71.53

74.83

Capital work-in-progress

1.33

2.20

4.02

24.24

6.90

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

914.68

779.87

689.73

610.59

480.07

Less : current liabilities & provisions

396.18

345.17

318.54

341.92

261.00

Total net current assets

518.50

434.70

371.19

268.67

219.07

Miscellaneous expenses not written

-

-

-

-

-

Total

588.69

511.39

456.17

364.44

300.80

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

132.28

124.60

89.17

69.19

32.57

Number of equity sharesoutstanding (Lacs)

250.00

250.00

250.00

250.00

250.00